Literature DB >> 11299778

Expression of tenascin and fibronectin in benign epithelial hyperplastic lesions and squamous carcinoma of the larynx.

N Zidar1, N Gale, V Kambic, J Fischinger.   

Abstract

BACKGROUND: Tenascin (T) and fibronectin (FN) are glycoprotein components of the extracellular matrix presumably involved in cancer progression. We analyzed their expression in epithelial hyperplastic lesions (EHL) and squamous carcinoma (SC) of the larynx.
MATERIALS AND METHODS: Samples from resected larynges of 30 patients with SC, and laryngeal biopsies of 28 patients with EHL, SC or benign reactive conditions were included. Immunohistochemistry was performed with antibodies against T and FN.
RESULTS: T and FN gradually increased with the grade of EHL and were markedly increased in the majority of SC. In SC, expression of T and FN correlated with the degree of desmoplasia but was inversely related to the density of lymphocytic stromal infiltration and the differentiation of SC. T and FN were also positive in benign reactive conditions.
CONCLUSION: T and FN immunostaining provides useful information on epithelial-stromal interaction in laryngeal EHL and SC but should not be regarded as a reliable stromal marker of malignancy. Our results supported the postulated diversified nature of the tumor stroma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299778

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Examination of oral cancer biomarkers by tissue microarray analysis.

Authors:  Peter Choi; C Diana Jordan; Eduardo Mendez; John Houck; Bevan Yueh; D Gregory Farwell; Neal Futran; Chu Chen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-05

Review 2.  The role of matrix extracellular proteins and metalloproteinases in head and neck carcinomas: an updated review.

Authors:  Antonio L A Pereira; Simone S L Veras; Ericka J D Silveira; Flávio R G Seabra; Leão Pereira Pinto; Lélia B Souza; Roseana A Freitas
Journal:  Braz J Otorhinolaryngol       Date:  2006-01-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.